Palomar Holdings, Inc. filings document the regulatory record of a specialty property and casualty insurer with common stock listed on Nasdaq. Its 8-K reports disclose quarterly and annual results, including underwriting metrics, premium growth, loss ratios, combined ratios, non-GAAP measures and related earnings releases.
Palomar’s SEC filings also cover capital-structure and corporate matters, including share repurchase authorizations, credit facilities, material agreements and completed acquisition activity affecting its subsidiary base. Proxy materials document annual meeting proposals, board governance, executive compensation and stockholder voting matters, while Regulation FD filings provide investor presentation materials and risk-related disclosure language.
Palomar Holdings, Inc. (PLMR) – Form 144 filing (Rule 144 Notice of Proposed Sale)
The filing discloses a planned disposition of 787 common shares through Morgan Stanley Smith Barney LLC, targeting the NASDAQ on or after 26-27 June 2025. Based on the stated aggregate market value of $122,543, the implied transaction price is roughly $155.8 per share.
The selling securityholder acquired the stock as restricted stock compensation on the same date and holds a separate block of 1,312 restricted shares. There are 26.7 million shares outstanding; therefore, the proposed sale represents less than 0.003 % of total shares, indicating minimal dilution or market supply pressure.
No other sales were disclosed for the past three months, and the signer affirms no undisclosed material adverse information exists. The form contains no financial performance data, corporate developments, or executive changes.
Investor takeaway: The notice is routine, low-volume, and unlikely to affect share price or corporate fundamentals. Its importance is chiefly procedural, signalling potential liquidity by an insider or employee receiving equity compensation, without indicating a change in strategic outlook or financial health.
Mac Armstrong, CEO, Chairman and Director of Palomar Holdings (PLMR), reported significant insider trading activity on June 23, 2025. The executive disposed of 5,000 shares at a weighted average price of $158.14 per share through the Armstrong Family Trust.
Following the transaction, Armstrong's holdings include:
- 70,186 shares held directly, including 2,555 shares purchased through the company's Employee Stock Purchase Plan (ESPP)
- 387,388 shares held indirectly through the Armstrong Family Trust after the reported sale
The shares were sold in multiple transactions with prices ranging from $155.61 to $159.91. This Form 4 filing was submitted by Angela Grant, Attorney-in-Fact, on June 25, 2025.
A Form 144 has been filed for Palomar Holdings indicating a proposed sale of 5,000 shares of common stock with an aggregate market value of $778,350. The sale is planned to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange, with an approximate sale date of June 23, 2025.
The shares were originally acquired as Restricted Stock Units from the issuer on January 26, 2024. The filing also discloses previous sales by the Armstrong Family Trust over the past 3 months:
- May 21, 2025: 5,000 shares sold for $809,798
- April 21, 2025: 5,000 shares sold for $727,032
- April 15, 2025: 3,202 shares sold for $490,042
These transactions appear to be part of a 10b5-1 trading plan. The company currently has 26,742,141 shares outstanding.
Palomar Holdings, Inc. (PLMR) – Form 4 insider transaction
Chief Financial Officer T. Christopher Uchida reported a sale of 500 common shares on 06/18/2025 at an average price of $158.69, generating proceeds of roughly $79 K. Following the transaction, Uchida’s direct ownership declined from 7,920 to 7,420 shares. No derivative transactions or 10b5-1 plan indications were disclosed, and the filing was made solely by one reporting person. The sale represents a small fraction of both the executive’s holdings and Palomar’s total shares outstanding, suggesting limited impact on the company’s overall insider ownership profile.